Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Espiard, Marie-Laure
Lecardeur, Laurent
Abadie, Pascale
Halbecq, Isabelle
and
Dollfus, Sonia
2006.
Trastorno perceptivo persistente por alucinógenos después del consumo de psilocibina: un estudio clínico.
European psychiatry (Ed. Española),
Vol. 13,
Issue. 3,
p.
141.
Kurzweg, V.
2007.
Suchtmittel in der AINS.
p.
129.
Wong, Eileen
Patel, Jayendra K.
and
Guzofski, Sarah
2008.
A worldwide yearly survey of new data and trends in adverse drug reactions and interactions.
Vol. 30,
Issue. ,
p.
31.
Vervaeke, Hylke
2008.
Drugs en alcohol; Gebruik, misbruik en verslaving.
p.
305.
Cunningham, Nicola
2008.
Hallucinogenic plants of abuse.
Emergency Medicine Australasia,
Vol. 20,
Issue. 2,
p.
167.
2009.
Meyler's Side Effects of Psychiatric Drugs.
p.
451.
Wong, Eileen
Patel, Jayendra K.
and
Langenfeld, Sarah
2009.
Vol. 31,
Issue. ,
p.
33.
Scott, Katherine
and
Lust, Karin
2010.
Illicit substance use in pregnancy – a review.
Obstetric Medicine,
Vol. 3,
Issue. 3,
p.
94.
Javors, Martin A.
King, Thomas S.
Ginsburg, Brett C.
and
Gerak, Lisa R.
2010.
Addiction Medicine.
p.
283.
Baggott, M.J.
Coyle, J.R.
Erowid, E.
Erowid, F.
and
Robertson, L.C.
2011.
Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire.
Drug and Alcohol Dependence,
Vol. 114,
Issue. 1,
p.
61.
Studerus, Erich
Kometer, Michael
Hasler, Felix
and
Vollenweider, Franz X
2011.
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.
Journal of Psychopharmacology,
Vol. 25,
Issue. 11,
p.
1434.
Hermle, Leo
Simon, Melanie
Ruchsow, Martin
and
Geppert, Martin
2012.
Hallucinogen-persisting perception disorder.
Therapeutic Advances in Psychopharmacology,
Vol. 2,
Issue. 5,
p.
199.
2012.
Medical Toxicology of Drug Abuse.
p.
950.
Stebelska, Katarzyna
2013.
Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol.
Therapeutic Drug Monitoring,
Vol. 35,
Issue. 4,
p.
420.
Subramanian, N.
and
Doran, M.
2014.
Improvement of hallucinogen persisting perception disorder (HPPD) with oral risperidone: case report.
Irish Journal of Psychological Medicine,
Vol. 31,
Issue. 1,
p.
47.
Korpi, Esa R.
den Hollander, Bjørnar
Farooq, Usman
Vashchinkina, Elena
Rajkumar, Ramamoorthy
Nutt, David J.
Hyytiä, Petri
Dawe, Gavin S.
and
Koulu, Markku
2015.
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse.
Pharmacological Reviews,
Vol. 67,
Issue. 4,
p.
872.
Majić, Tomislav
Schmidt, Timo T.
and
Hermle, Leo
2016.
Handbuch Psychoaktive Substanzen.
p.
1.
Beuhler, Michael C.
2016.
Critical Care Toxicology.
p.
1.
Nichols, David E.
and
Barker, Eric L.
2016.
Psychedelics.
Pharmacological Reviews,
Vol. 68,
Issue. 2,
p.
264.
2016.
Meyler's Side Effects of Drugs.
p.
1048.
Comments
No Comments have been published for this article.